The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor DNA (ctDNA) clearance after immune checkpoint inhibition (ICI) with radiotherapy (RT) as a prognostic indicator for patients with advanced melanoma.
 
Alyssa Steimle
No Relationships to Disclose
 
Amir Forati
No Relationships to Disclose
 
Alice Zhou
Consulting or Advisory Role - Optune (I)
 
Trevor McCracken
No Relationships to Disclose
 
Meena Hosny
No Relationships to Disclose
 
Golbarg Rahimi
No Relationships to Disclose
 
Janmesh Patel
No Relationships to Disclose
 
Caroline Burkey
No Relationships to Disclose
 
Jessica Caraway
No Relationships to Disclose
 
Andrew Wood
Employment - Marathon Pharma (I)
 
Madison Harris
No Relationships to Disclose
 
Alexander Birbrair
No Relationships to Disclose
 
Deepak Sahasrabudhe
No Relationships to Disclose
 
Fauzia Hollnagel
No Relationships to Disclose
 
Gary Doolittle
No Relationships to Disclose
 
Adam Burr
No Relationships to Disclose
 
Nina Mathew
No Relationships to Disclose
 
Gino In
Honoraria - Array BioPharma/Pfizer; Bristol-Myers Squibb; Pfizer; regeneron; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Castle Biosciences; Novartis; Pfizer; Replimune; Sanofi
Speakers' Bureau - Merck; Regeneron; Rockpointe CME; Targeted Oncology
Research Funding - Bicara Therapeutics (Inst); Checkmate Pharmaceuticals (Inst); Georgiamune (Inst); Idera (Inst); Immunocore (Inst); Instil Bio (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); Obsidian Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Replimune (Inst); TuHura (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Pfizer; Pfizer; Regeneron
 
Adrienne Victor
Honoraria - Rosenthal Research
Consulting or Advisory Role - Atheneum; Foundation Medicine; Genzyme; OMNI Health Media; SpringWorks Therapeutics
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Foundation Medicine
 
Vincent Ma
Honoraria - CAHON; Conquer Cancer, the ASCO Foundation; Society for Immunotherapy of Cancer
Consulting or Advisory Role - Bristol Myers Squibb; Delcath Systems; General Dynamics Information Technology; IDEAYA Biosciences; Immunocore; Incyte; MDoutlook; Partner Therapeutics; Regeneron; Replimune; Targeted Oncology; Teiko.bio; Y-mAbs Therapeutics
Research Funding - AIQ Solutions (Inst); Aminex (Inst); Astellas Pharma (Inst); C4 Therapeutics (Inst); Delcath Systems; Fujifilm (Inst); immatics (Inst); Immuneering (Inst); Immunocore (Inst); Innate Pharma (Inst); Jounce Therapeutics (Inst); Krystal Biotech (Inst); Marengo Therapeutics (Inst); Merck (Inst); Natera (Inst); Pfizer (Inst); Regeneron (Inst); Replimune (Inst); Seagen (Inst); Top Alliance BioScience (Inst); TuHura Biosciences (Inst); Y-mAbs Therapeutics (Inst)
Travel, Accommodations, Expenses - CAHON; Delcath Systems; Erasca, Inc; Immunocore; Incyte; Regeneron